Hot Products

ONLINE INQUIRY

Human Brain Microvascular Endothelial Cells

Cat.No.: CSC-C1503

Species: Human

Source: Brain

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
  • Publications
Cat.No.
CSC-C1503
Description
Human Brain Microvascular Endothelial Cells from Creative Bioarray are isolated from human brain tissue. Human Brain Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryopreserved in vails. Each vial contains at least 0.5×10^6 cells per ml. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic beads pre-coated with secondary antibody.
Species
Human
Source
Brain
Recommended Medium
It is recommended to use Endothelial Cell Medium for the culturing of HBMEC in vitro.
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Normal
Quality Control
Human Brain Microvascular Endothelial Cells from Creative Bioarray display typical cobblestone with large dark nuclei appearance under light microscopy. Cells are tested for expression of endothelial cell marker using antibody, CD31 (Catalog No. 550389, BD; CD31/PECAM-1 PE-conjugated Antibody, Catalog No. FAB3567P, R&D) or VE-Cadherin (FITC-VE-cadherin Catalog No. 560411, BD) by immunofluorescence staining or FACS. All cells test negative for mycoplasma, bacteria, yeast, and fungi. HIV-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. Per request, a Certificate of Analysis will be provided for each cell lot purchased. Cells can be expanded for 3-5 passages under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human brain microvascular endothelial cells (HBMECs) represent a specialized endothelial cell type located in cerebral micro-vessels which serves as an essential component of the blood-brain barrier. Brain endothelial barrier cells contain multiple tight junctions that create high trans-endothelial resistance to reduce paracellular flux and block substance entry from the bloodstream into the brain. The absence of fenestrae combined with reduced transcytosis levels for fluid-phase substances in HBMECs strengthens the barrier function compared to peripheral endothelial cells. These cells contain asymmetrically localized enzymes together with transporter systems that enable directional substance transport which maintains blood-brain barrier homeostasis.

The use of HBMECs is essential for drug permeability research because they provide a method to assess the ability of pharmaceuticals to penetrate the blood-brain barrier. The transport of neurotrophic factors by these cells helps to understand nervous system development and repair mechanisms. HBMVECs express adhesion molecules like ICAM-1 and VCAM-1 that control leukocyte movement and immune system activities. This feature makes them an important tool for studying immune-mediated brain injuries and neuroinflammation.

Immunofluorescent staining was conducted on BMEC marker proteins, which include adherence junction proteins (CD31, VE-cadherin), tight junction proteins (Occludin, claudin 5, ZO-1), and the glucose transporter Glut-1. Scale bars represent 100 µm.Fig. 1. Immunofluorescent staining of BMEC marker proteins, including adherence junction proteins (CD31, VE-cadherin), tight junction proteins (Occludin, claudin 5, ZO-1), and glucose transporter, Glut-1. Scale bars, 100 µm (Zhang W, Zhao X, et al., 2023).

BMEC Microvasculatures Have a Better Endothelial Barrier Function than HUVEC Microvasculatures

Endothelial cells (ECs) specialized to organs have specific vascular features that are vital for ensuring function in the organ, particularly the BBB. While the literature has traditionally not included such important in vivo parameters as 3D structure and pericyte coverage, this has prevented simulations of genuine microvascular environments in vitro.

Uwamori's team employed a microfluidic platform to mimic such an environment by co-culturing human brain microvascular endothelial cells (BMECs) with mesenchymal stem cells (MSCs), allowing for evaluation of differences in vascular formation and barrier functions compared to human umbilical vein endothelial cells (HUVECs). They evaluated the endothelial barrier performance of 7-day-old microvasculatures derived from BMECs or HUVECs. Fluorescence dextran solution was introduced into microvascular networks for time-lapse imaging. We successfully introduced it into capillaries with diameters < 10 μm (Fig. 1A–C), and images confirmed the lumens were filled without leakage (Fig. 1B). They also plotted dextran diffusion from the vessels inside to the outside, and found sharp peaks around the wall of the capillary (Fig. 1D). Within 3 μm of the capillary wall, extravascular fluorescence increased over time (Fig. 1E). Permeability values for 70 kDa dextran ranged from 0.910 ± 0.405×10−7 cm/s in BMEC microvasculatures to 2.743 ± 0.550×10−7 cm/s in HUVEC microvasculatures (Fig. 1F), suggesting that the endothelial barrier function of BMEC microvasculatures was significantly more robust than that of HUVEC microvasculatures.

Perfusion of fluorescent dextran into engineered microvasculatures.Fig. 1. Fluorescence dextran perfusion into constructed microvasculatures (Uwamori H, Ono Y, et al., 2020).

Des-Arg-9-BK Stimulates Secretion of Pro-Inflammatory Cytokines by hCMVEC Cells

Neuroinflammatory diseases like Alzheimer's and Parkinson's are marked by chronic inflammation and dysfunctional vascularity. These neuroinflammatory states are caused by activation of the Bradykinin 1 receptor (B1R), but no one understands how exactly B1R promotes inflammation and vascular dysfunction. Mugisho et al. assessed the impact of B1R stimulation via Des-Arg-9-BK on hCMVECs.

The levels of IL-6 and IL-8 in hCMVEC cells were used to assess endothelial inflammation at 4, 24, and 72 hours after treatment (Fig. 2). Des-Arg-9-BK treatment significantly boosted IL-6 at 24 hours and 72 hours, but not 4 hours. Expression of IL-8 increased dramatically at 72 hours, but not at earlier intervals. They also quantified the release of adhesion proteins ICAM-1 and VCAM-1, which significantly increased at 4, 24, and 72 hours after Des-Arg-9-BK administration. The levels of MCP-1 and VEGF were measured for leucocyte recruitment proteins (Fig. 2). Des-Arg-9-BK reduced MCP-1 by an order of magnitude at 24 hours but raised it at 72 hours. At 4 hours nothing was different. VEGF expression was significantly lower at 72 hours and did not change at 4 or 24 hours. These results indicated Des-Arg-9-BK stimulates secretion of pro-inflammatory cytokines by hCMVEC cells.

The impact of Des-Arg-9-BK stimulation on the secretion of IL-6, IL-8, ICAM-1, VCAM-1, MCP-1, and VEGF in hCMVEC cultures was evaluated.Fig. 2. Effect of Des-Arg-9-BK stimulation on the secretion of IL-6, IL-8, ICAM-1, VCAM-1, MCP-1 and VEGF by hCMVEC cultures (Mugisho OO, Robilliard LD, et al., 2019).

Do you have immortalized?

Yes, we can provide Immortalized Human Brain Microvascular Endothelial Cells.

Ask a Question

Write your own review

For research use only. Not for any other purpose.